Asthma in Australia 2008 

Figure 6.12
Use of inhaled corticosteroids among children, by potency class, age and number of prescriptions, 2006

Notes

1. Least potent includes Becotide 100, Becotide MDI 100, Qvar 50, Qvar 50 autohaler, Pulmicort meter aero 100, Pulmicort turbuhaler, Alvesco 80, Flixotide jnr accuhaler, Flixotide jnr Oral pressurised inhalation 50 micrograms per dose (120 doses) CFC-free formulation, Seretide accuhaler 100/50, Seretide MDI 50/25, Symbicort turbuhaler 100/6.

2. Intermediate level includes Respocort inhaler Becloforte MDI 250, Respocort autohaler 250, Qvar 100, Qvar 100 autohaler, Pulmicort respules, Pulmicort meter aero 200, Pulmicort turbuhaler, Alvesco 160, Flixotide accuhaler, Flixotide, Seretide accuhaler 250/50, Seretide MDI 125/25, Symbicort turbuhaler 200/6.

3. Most potent includes Pulmicort respules, Pulmicort turbuhaler, Flixotide accuhaler, Flixotide, Seretide accuhaler 500/50, Seretide MDI 250/25, Symbicort turbuhaler 400/12.

4. Children have been classified according to the most potent formulation of inhaled corticosteroid prescription they received in 2006.

Sources: Pharmaceutical Benefits Scheme; Australian Bureau of Statistics.

Data table

Age Group Potency Level
1
2–3
4–6
7–12
13+
0 to 4 years Least potent 1.078362 0.48592 0.175295 0.055477 0.00298
Intermediate 0.315592 0.138845 0.054713 0.015436 0.001299
Most potent 0.042028 0.012608 0.002751 0.000611 0.000153
5 to 14 years Least potent 0.973959 0.465695 0.200876 0.06781 0.003356
Intermediate 1.077661 0.530222 0.221923 0.068722 0.003648
Most potent 0.296736 0.133467 0.049754 0.014007 0.000802

Note: To export data table into Excel, 'Right click' on table and select 'Export to Microsoft Excel'

<<Return to List of Figures>>

<<Return to Table of Contents>>

 

© Australian Institute of Health and Welfare 2008

This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced without prior written permission from the Australian Institute of Health and Welfare. Requests and enquiries concerning reproduction and rights should be directed to the Head, Media and Publishing, Australian Institute of Health and Welfare, GPO Box 570, Canberra ACT 2601.